MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 16, 2011, Pages 6573-6578

  Moussay, Etienne ^a   Wang, Kai ^b   Cho, Ji Hoon ^b   Van Moer, Kris ^a   Pierson, Sandrine ^a   Paggetti, Jérôme ^a   Nazarov, Petr V ^a   Palissot, Valérie ^a   Hood, Leroy E ^b,c   Berchem, Guy ^a,d   Galas, David J ^b,c  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^d CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

Author keywords

Gene network; Hairy cell leukemia; Multiple myeloma; NR6A1

Indexed keywords

MICRORNA; MICRORNA 20A; PROTEIN BCL 2; PROTEIN KINASE ZAP 70; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

EID: 79955582317     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1019557108     Document Type: Article

References (36)

1. Hamblin TJ (2009) Just exactly how common is CLL? Leuk Res 33:1452-1453.
2. Kay NE, Shanafelt TD (2007) Prognostic factors in chronic lymphocytic leukemia. Curr Hematol Malig Rep 2:49-55. (Pubitemid 46953001)
3. Schweighoffer E, Vanes L, Mathiot A, Nakamura T, Tybulewicz VL (2003) Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion. Immunity 18: 523-533. (Pubitemid 36513634)
4. Tsimberidou AM, Keating MJ (2009) Treatment of fludarabine-refractory chronic lymphocytic leukemia. Cancer 115:2824-2836.
5. Rai KR, et al. (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46: 219-234.
6. Binet JL, Vaugier G, Dighiero G, d'Athis P, Charron D (1977) Investigation of a new parameter in chronic lymphocytic leukemia: The percentage of large peripheral lymphocytes determined by the Hemalog D. Prognostic significance. Am J Med 63: 683-688.
7. Chim SS, et al. (2008) Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54:482-490. (Pubitemid 351348154)
8. Kitada S, et al. (1998) Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vivo chemoresponses. Blood 91:3379-3389. (Pubitemid 28193890)
9. McManus MT (2003) MicroRNAs and cancer. Semin Cancer Biol 13:253-258.
10. Klein U, et al. (2010) The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17:28-40.
11. Calin GA, et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793-1801. (Pubitemid 41549891)
12. Stamatopoulos B, et al. (2009) MicroRNA-29c and microRNA-223 downregulation has invivosignificancein chronic lymphocytic leukemiaandimprovesdiseaseriskstratification. Blood 113:5237-5245.
13. Mitchell PS, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513-10518.
14. Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110:13-21. (Pubitemid 351853251)
15. Tsujiura M, et al. (2010) Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102:1174-1179.
16. Wang K, et al. (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106:4402-4407.
17. Haferlach C, Dicker F, Schnittger S, KernW, Haferlach T (2007) Comprehensive genetic characterization of CLL: A study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 21: 2442-2451. (Pubitemid 350148886)
18. Resnick KE, et al. (2009) The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 112:55-59.
19. Wang K, Zhang S, Weber J, Baxter D, Galas DJ (2010) Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 38:7248-7259.
20. Fulci V, et al. (2007) Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109:4944-4951. (Pubitemid 46827793)
21. Burger JA, Kipps TJ (2002) Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells. Leuk Lymphoma 43:461-466. (Pubitemid 34232911)
22. Kurtova AV, et al. (2009) Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: Development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 114:4441-4450.
23. Bichi R, et al. (2002) Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 99:6955-6960. (Pubitemid 34526239)
24. Cimmino A, et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102:13944-13949. (Pubitemid 41377683)
25. Vrhovac R, et al. (1998) Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia. Blood 91:4694-4700. (Pubitemid 28270319)
26. de Totero D, et al. (2008) The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways. Blood 111:517-524.
27. Redondo-Muñoz J, José Terol M, García-Marco JA, García-Pardo A (2008) Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration. Blood 111:383-386.
28. Orchard JA, et al. (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 363:105-111. (Pubitemid 38068326)
29. Grinchuk OV, Jenjaroenpun P, Orlov YL, Zhou J, Kuznetsov VA (2010) Integrative analysis of the human cis-antisense gene pairs, miRNAs and their transcription regulation patterns. Nucleic Acids Res 38:534-547.
30. Katayama S, et al.; RIKEN Genome Exploration Research Group; Genome Science Group (Genome Network Project Core Group); FANTOM Consortium (2005) Antisense transcription in the mammalian transcriptome. Science 309:1564-1566.
31. He L, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435:828-833. (Pubitemid 40839734)
32. Ventura A, et al. (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132:875-886. (Pubitemid 351312807)
33. Levy C, et al. (2010) Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell 40:841-849.
34. Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH (2009) Exosomal microRNA: A diagnostic marker for lung cancer. Clin Lung Cancer 10:42-46.
35. Stamatopoulos B, et al. (2007) Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. Clin Chem 53: 1757-1766. (Pubitemid 47509668)
36. Rosenwald A, et al. (2004) Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood 104:1428-1434. (Pubitemid 39166521)